332
Views
111
CrossRef citations to date
0
Altmetric
Original Research

Sarcopenia correlates with systemic inflammation in COPD

, , , &
Pages 669-675 | Published online: 20 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (11)

Yanxia Han, Zhenyun Wu, Qian Zhao, Bo Jiang, Xiaolang Miao, Xiangmin Lu, Hongying Qian & Meie Niu. (2022) Association Between Anthropometric Indices and Skeletal-Muscle Atrophy in Chinese Patients with Stable Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2529-2539.
Read now
Kaveh Gaynor-Sodeifi, Hayley Lewthwaite, Alex Robert Jenkins, Letícia Fernandes Belo, Emily Koch, Ahzum Mujaddid, Dana Raffoul, Lauren Tracey & Dennis Jensen. (2022) The Association between Fat-Free Mass and Exercise Test Outcomes in People with Chronic Obstructive Pulmonary Disease: A Systematic Review. COPD: Journal of Chronic Obstructive Pulmonary Disease 19:1, pages 182-205.
Read now
Nnamdi Mgbemena, Anne Jones & Anthony S. Leicht. (2022) Relationship between handgrip strength and lung function in adults: a systematic review. Physiotherapy Theory and Practice 38:12, pages 1908-1927.
Read now
Baiyang Lin, Li Bai, Shenglong Wang & Hong Lin. (2021) The Association of Systemic Interleukin 6 and Interleukin 10 Levels with Sarcopenia in Elderly Patients with Chronic Obstructive Pulmonary Disease. International Journal of General Medicine 14, pages 5893-5902.
Read now
Jiaxi Zhao, Yiqin Huang & Xiaofeng Yu. (2021) A Narrative Review of Gut-Muscle Axis and Sarcopenia: The Potential Role of Gut Microbiota. International Journal of General Medicine 14, pages 1263-1273.
Read now
Sophie I J van Bakel, Harry R Gosker, Ramon C Langen & Annemie M W J Schols. (2021) Towards Personalized Management of Sarcopenia in COPD. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 25-40.
Read now
V. K. S. Lage, G. P. Silva, A. C. R. Lacerda, F. A. Paula, L. P. Lima, J. N. V. Santos, H. C. Almeida, A. G. F. Pinto, P. H. S. Figueiredo, H. S. Costa, M. Bernardo-Filho, D. C. Sá-Caputo, R. Taiar, H. R. Leite, A. L. Teixeira & V. A. Mendonça. (2021) Functional tests associated with sarcopenia in moderate chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 15:4, pages 569-576.
Read now
Juliana Souza Uzeloto, Alessandra Choqueta de Toledo-Arruda, Bruna Spolador de Alencar Silva, Marjorie de Assis Golim, Aline Márcia Marques Braz, Fabiano Francisco de Lima, Isis Grigoletto & Ercy Mara Cipulo Ramos. (2020) Systemic Cytokine Profiles of CD4+ T Lymphocytes Correlate with Clinical Features and Functional Status in Stable COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2931-2940.
Read now
Kyung Soo Hong, Min Cheol Kim & June Hong Ahn. (2020) Sarcopenia Is an Independent Risk Factor for NAFLD in COPD: A Nationwide Survey (KNHANES 2008–2011). International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1005-1014.
Read now
Mariangela Rondanelli, Milena Anna Faliva, Gabriella Peroni, Vittoria Infantino, Clara Gasparri, Giancarlo Iannello, Simone Perna, Tariq AbdulKarim Alalwan, Salwa Al-Thawadi & Angelo Guido Corsico. (2020) Food Pyramid for Subjects with Chronic Obstructive Pulmonary Diseases. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1435-1448.
Read now
Jeong Uk Lim, Chang Dong Yeo, Chin Kook Rhee, Yong Hyun Kim, Chan Kwon Park, Ju Sang Kim, Jin Woo Kim, Seung Joon Kim, Hyoung Kyu Yoon & Sang Haak Lee. (2018) Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2139-2146.
Read now

Articles from other publishers (100)

Mingming Deng, Qin Zhang, Liming Yan, Yiding Bian, Ruixia Li, Jinghan Gao, Yingxi Wang, Jinrui Miao, Jiaye Li, Xiaoming Zhou & Gang Hou. (2023) Glycyl‐ l ‐histidyl‐ l ‐lysine‐Cu 2+ rescues cigarette smoking‐induced skeletal muscle dysfunction via a sirtuin 1‐dependent pathway . Journal of Cachexia, Sarcopenia and Muscle 14:3, pages 1365-1380.
Crossref
Felipe V.C. Machado, Claus F. Vogelmeier, Rudolf A. Jörres, Henrik Watz, Robert Bals, Tobias Welte, Martijn A. Spruit, Peter Alter & Frits M.E. Franssen. (2023) Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications. Chest 163:5, pages 1071-1083.
Crossref
E. S. Pan’ko, S. V. Zhavoronok, A. M. Solovchuk, S. S. Pan’ko & S. V. Pan’ko. (2023) Predictors of length of hospital stay in patients with acute COVID-19. Journal Infectology 15:1, pages 86-92.
Crossref
Angela Tramontano & Paolo Palange. (2023) Nutritional State and COPD: Effects on Dyspnoea and Exercise Tolerance. Nutrients 15:7, pages 1786.
Crossref
Shuai-Wen Huang, Hong Long, Zhong-Min Mao, Xing Xiao, Ailin Chen, Xin Liao, Mei Wang, Qiong Zhang, Ye Hong & Hong-Lian Zhou. (2023) A Nomogram for Optimizing Sarcopenia Screening in Community-dwelling Older Adults: AB3C Model. Journal of the American Medical Directors Association 24:4, pages 497-503.
Crossref
Jessica Schultz, Amanda R. Vest, Maria Masotti, Austin Hoeg, Levi Teigen, Ranjit John, Andrew Shaffer, Tamas Alexy, Cindy Martin & Rebecca Cogswell. (2023) Body mass index and natriuretic peptides trends before and after left ventricular assist device. JCSM Rapid Communications.
Crossref
Jie He, Hezhi Li, Jun Yao & Yan Wang. (2023) Prevalence of sarcopenia in patients with COPD through different musculature measurements: An updated meta-analysis and meta-regression. Frontiers in Nutrition 10.
Crossref
Manuel Gómez-Martínez, Wendy Rodríguez-García, Dulce González-Islas, Arturo Orea-Tejeda, Candace Keirns-Davis, Fernanda Salgado-Fernández, Samantha Hernández-López, Angelia Jiménez-Valentín, Alejandra Vanessa Ríos-Pereda, Juan Carlos Márquez-Cordero, Mariana Salvatierra-Escobar & Iris López-Vásquez. (2023) Impact of Body Composition and Sarcopenia on Mortality in Chronic Obstructive Pulmonary Disease Patients. Journal of Clinical Medicine 12:4, pages 1321.
Crossref
Alyson Deprez, Zakaria Orfi, Lupann Rieger & Nicolas Alexandre Dumont. (2023) Impaired muscle stem cell function and abnormal myogenesis in acquired myopathies. Bioscience Reports 43:1.
Crossref
Arpad Hasenauer, Céline Forster, Johan Hungerbühler, Jean Yannis Perentes, Etienne Abdelnour-Berchtold, Joachim Koerfer, Thorsten Krueger, Fabio Becce & Michel Gonzalez. (2023) CT-Derived Sarcopenia and Outcomes after Thoracoscopic Pulmonary Resection for Non-Small Cell Lung Cancer. Cancers 15:3, pages 790.
Crossref
颖 张. (2023) Research Progress of Chronic Obstructive Pulmonary Disease Complicated with Sarcopenia. Advances in Clinical Medicine 13:04, pages 6820-6825.
Crossref
Yuto Takada, Yoshimasa Takafuji, Yuya Mizukami, Takashi Ohira, Naoyuki Kawao, Kiyotaka Okada & Hiroshi Kaji. (2022) Tumor Necrosis Factor-α Blunts the Osteogenic Effects of Muscle Cell-Derived Extracellular Vesicles by Affecting Muscle Cells. Calcified Tissue International 112:3, pages 377-388.
Crossref
Ying Wang, Sidong Li, Zhenyi Zhang, Shiqi Sun, Juntao Feng, Jinbiao Chen, Yigang Pei & Xianjing Peng. (2022) Accelerated loss of trunk muscle density and size at L1 vertebral level in male patients with COPD. Frontiers in Endocrinology 13.
Crossref
Bruno Ribeiro Baptista, Thomas d’Humières, Frédéric Schlemmer, Inès Bendib, Grégoire Justeau, Lara Al-Assaad, Mouna Hachem, Rebecca Codiat, Benjamin Bardel, Laure Abou Chakra, Thibaut Belmondo, Etienne Audureau, Sophie Hue, Armand Mekontso-Dessap, Geneviève Derumeaux & Laurent Boyer. (2022) Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort. Respiratory Research 23:1.
Crossref
Konstantinos Prokopidis & Oliver C. Witard. (2021) Understanding the role of smoking and chronic excess alcohol consumption on reduced caloric intake and the development of sarcopenia. Nutrition Research Reviews 35:2, pages 197-206.
Crossref
Zhigang Hu, Ailan Yang, Yufeng Tian & Xinyu Song. (2022) Daytime napping, comorbidity profiles, and the risk of sarcopenia in older individuals. Frontiers in Physiology 13.
Crossref
Yong Suk Jo. (2022) Long-Term Outcome of Chronic Obstructive Pulmonary Disease: A Review. Tuberculosis and Respiratory Diseases 85:4, pages 289-301.
Crossref
Lijiao Zhang, Chunxiao Li, Jing Xiong, Chun Chang & Yongchang Sun. (2022) Dysregulated myokines and signaling pathways in skeletal muscle dysfunction in a cigarette smoke–induced model of chronic obstructive pulmonary disease. Frontiers in Physiology 13.
Crossref
Emanuela Tudorache, Ovidiu Fira-Mladinescu, Daniel Traila, Monica Marc, Ruxandra Mioara Rajnoveanu, Doina Ecaterina Tofolean & Ariadna Petronela Fildan. (2022) Endothelial dysfunction: The possible link between cardiovascular comorbidities and phenomenon of inflammaging from COPD. Medicine 101:33, pages e30078.
Crossref
Hans Lennart Persson, Apostolos Sioutas, Magnus Kentson, Petra Jacobson, Peter Lundberg, Olof Dahlqvist Leinhard & Mikael Fredrik Forsgren. (2022) Skeletal Myosteatosis is Associated with Systemic Inflammation and a Loss of Muscle Bioenergetics in Stable COPD. Journal of Inflammation Research Volume 15, pages 4367-4384.
Crossref
Makoto Yoshida, Tetsuya Hiramoto, Atsushi Moriwaki, Hisayuki Osoreda, Tomoaki Iwanaga & Hiromasa Inoue. (2022) Impact of extrapulmonary comorbidities on physical activity in chronic obstructive pulmonary disease in Japan: A cross-sectional study. PLOS ONE 17:7, pages e0270836.
Crossref
Kai Ma, Fengxiang Huang, Ruiping Qiao & Lijun Miao. (2022) Pathogenesis of sarcopenia in chronic obstructive pulmonary disease. Frontiers in Physiology 13.
Crossref
Jinghan Gao, Mingming Deng, Yanxia Li, Yan Yin, Xiaoming Zhou, Qin Zhang & Gang Hou. (2022) Resistin as a Systemic Inflammation-Related Biomarker for Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease. Frontiers in Nutrition 9.
Crossref
Vanessa Kelly da Silva Lage, Fabiana Angélica de Paula, Liliana Pereira Lima, Joyce Noelly Vítor Santos, Jousielle Márcia dos Santos, Ângela Alves Viegas, Guilherme Pinto da Silva, Hellen Cristina de Almeida, Ana Luiza da Silva Nunes Teixeira Rodrigues, Amanda Aparecida Oliveira Leopoldino, Núbia Carelli Pereira de Avelar, Ana Lúcia Danielewicz, Adriana Netto Parentoni, Antônio Lúcio Teixeira, Murilo Xavier Oliveira, Ana Cristina Rodrigues Lacerda & Vanessa Amaral Mendonça. (2022) Plasma levels of myokines and inflammatory markers are related with functional and respiratory performance in older adults with COPD and sarcopenia. Experimental Gerontology 164, pages 111834.
Crossref
Mingming Deng, Yiding Bian, Qin Zhang, Xiaoming Zhou & Gang Hou. (2022) Growth Differentiation Factor-15 as a Biomarker for Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease. Frontiers in Nutrition 9.
Crossref
Tanja Taivassalo & Russell T. Hepple. (2022) Integrating Mechanisms of Exacerbated Atrophy and Other Adverse Skeletal Muscle Impact in COPD. Frontiers in Physiology 13.
Crossref
Balázs Csoma, Maria Rosaria Vulpi, Silvano Dragonieri, Andrew Bentley, Timothy Felton, Zsófia Lázár & Andras Bikov. (2022) Hypercapnia in COPD: Causes, Consequences, and Therapy. Journal of Clinical Medicine 11:11, pages 3180.
Crossref
E. D. Bazdyrev, L. S. Gofman & O. L. Barbarash. (2022) Frailty syndrome in patients with respiratory diseases. PULMONOLOGIYA 32:2, pages 244-252.
Crossref
Emma L Watson, Luke A Baker, Tom J Wilkinson, Doug W Gould, Soteris Xenophontos, Matthew Graham-Brown, Rupert W Major, Robert U Ashford, Joao L Viana & Alice C Smith. (2022) Inflammation and physical dysfunction: responses to moderate intensity exercise in chronic kidney disease. Nephrology Dialysis Transplantation 37:5, pages 860-868.
Crossref
Nathalie Martínez-Luna, Arturo Orea-Tejeda, Dulce González-Islas, Laura Flores-Cisneros, Candace Keirns-Davis, Rocío Sánchez-Santillán, Ilse Pérez-García, Yael Gastelum-Ayala, Valeria Martínez-Vázquez & Óscar Martínez-Reyna. (2022) Association between body composition, sarcopenia and pulmonary function in chronic obstructive pulmonary disease. BMC Pulmonary Medicine 22:1.
Crossref
Rosanne J.H.C.G. Beijers, Frits M.E. Franssen, Miriam T.J. Groenen, Martijn A. Spruit & Annemie M.W.J. Schols. (2022) Physical and mental health profile of patients with the early-onset severe COPD phenotype: A cross-sectional analysis. Clinical Nutrition 41:3, pages 653-660.
Crossref
Mingming Deng, Xiaoming Zhou, Yanxia Li, Yan Yin, Chaonan Liang, Qin Zhang, Jingwen Lu, Mengchan Wang, Yu Wang, Yue Sun, Ruixia Li, Liming Yan, Qiuyue Wang & Gang Hou. (2022) Ultrasonic Elastography of the Rectus Femoris, a Potential Tool to Predict Sarcopenia in Patients With Chronic Obstructive Pulmonary Disease. Frontiers in Physiology 12.
Crossref
婷婷 张. (2022) Correlation of Chronic Obstructive Pulmonary Disease, Osteoporosis and Sarcopenia. Advances in Clinical Medicine 12:05, pages 4080-4085.
Crossref
Elizabeth Benz, Sara R.A. Wijnant, Katerina Trajanoska, Johnmary T. Arinze, Emmely W. de Roos, Maria de Ridder, Ross Williams, Frank van Rooij, Katia M.C. Verhamme, M. Arfan Ikram, Bruno H. Stricker, Fernando Rivadeneira, Lies Lahousse & Guy G. Brusselle. (2022) Sarcopenia, systemic immune-inflammation index and all-cause mortality in middle-aged and older people with COPD and asthma: a population-based study. ERJ Open Research 8:1, pages 00628-2021.
Crossref
Kohei Fujita, Hirotsugu Ohkubo, Akiko Nakano, Yuta Mori, Kensuke Fukumitsu, Satoshi Fukuda, Yoshihiro Kanemitsu, Takehiro Uemura, Tomoko Tajiri, Ken Maeno, Yutaka Ito, Tetsuya Oguri, Yoshiyuki Ozawa, Takayuki Murase & Akio Niimi. (2022) Frequency and impact on clinical outcomes of sarcopenia in patients with idiopathic pulmonary fibrosis. Chronic Respiratory Disease 19, pages 147997312211172.
Crossref
Mimi Thyregod, Anders Løkke, Søren T. Skou, Jacob Larsen & Uffe Bodtger. (2022) Changes in systemic inflammation after pulmonary rehabilitation in patients with COPD and severe physical inactivity – an exploratory study. Chronic Respiratory Disease 19, pages 147997312211124.
Crossref
Daniel T. Cannon, Leonardo Nogueira, Alma K. Gutierrez-Gonzalez, Natalie K. Gilmore, Timothy D. Bigby & Ellen C. Breen. (2022) Role of IL-33 receptor (ST2) deletion in diaphragm contractile and mitochondrial function in the Sugen5416/hypoxia model of pulmonary hypertension. Respiratory Physiology & Neurobiology 295, pages 103783.
Crossref
Jhonatan Betancourt-Peña, Juan Carlos Ávila-Valencia, Diana Milena Diaz-Vidal & Vicente Benavides-Córdoba. (2022) Differences in exercise capacity and health-related quality of life according to the body mass index in patients with COPD. Pulmonology 28:1, pages 70-72.
Crossref
Morgan P. McBee, Cody Woodhouse, Andrew T. Trout, James I. Geller, Ethan A. Smith, Bin Zhang & Alexander J. Towbin. (2021) Skeletal muscle mass as a marker to predict outcomes in children and young adults with cancer. Abdominal Radiology 47:1, pages 452-459.
Crossref
Foon Yin Fung & Ngiap Chuan Tan. (2021) Response to Revisiting: “Prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting”. BMC Geriatrics 21:1.
Crossref
Ann Ashworth. (2021) Sarcopenia and malnutrition: commonly occurring conditions in the older population. British Journal of Nursing 30:21, pages S4-S10.
Crossref
Linyuan Pan, Wenqing Xie, Xin Fu, Wenhao Lu, Hongfu Jin, Jieyu Lai, Aohan Zhang, Yongle Yu, Yusheng Li & Wenfeng Xiao. (2021) Inflammation and sarcopenia: A focus on circulating inflammatory cytokines. Experimental Gerontology 154, pages 111544.
Crossref
Roberto Cannataro, Leandro Carbone, Jorge L. Petro, Erika Cione, Salvador Vargas, Heidy Angulo, Diego A. Forero, Adrián Odriozola-Martínez, Richard B. Kreider & Diego A. Bonilla. (2021) Sarcopenia: Etiology, Nutritional Approaches, and miRNAs. International Journal of Molecular Sciences 22:18, pages 9724.
Crossref
Irina V. Kozlova & Anna P. Bykova. (2021) Osteosarcopenia in chronic pancreatitis. Terapevticheskii arkhiv 93:8, pages 869-875.
Crossref
Theerasuk Kawamatawong. (2021) Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases. Frontiers in Pharmacology 12.
Crossref
Pei-Jane Bair, Ning-Yi Hsia, Cheng-Li Lin, Yu-Cih Yang, Te-Chun Shen & Chi‐Yuan Li. (2021) Population-based retrospective cohort study on risk of age-related macular degeneration in people with chronic obstructive pulmonary disease. Scientific Reports 11:1.
Crossref
Yong Jun Choi, Do Sun Kwon, Taehee Kim, Jae Hwa Cho, Hyung Jung Kim, Min Kwang Byun & Hye Jung Park. (2021) Low alanine aminotransferase as a risk factor for chronic obstructive pulmonary disease in males. Scientific Reports 11:1.
Crossref
Mingshan Xue, Yifeng Zeng, Runpei Lin, Hui-Qi Qu, Teng Zhang, Xiaohua Douglas Zhang, Yueting Liang, Yingjie Zhen, Hao Chen, Zhifeng Huang, Haisheng Hu, Peiyan Zheng, Hakon Hakonarson, Luqian Zhou & Baoqing Sun. (2021) Metabolomic profiling of anaerobic and aerobic energy metabolic pathways in chronic obstructive pulmonary disease. Experimental Biology and Medicine 246:14, pages 1586-1596.
Crossref
Vitalii Poberezhets, Szymon Skoczyński, Anna Demchuk, Aleksandra Oraczewska, Ewelina Tobiczyk, Yuriy Mostovoy & Adam Barczyk. (2021) Sarcopenia in COPD patients: Prevalence, patients’ characteristics and predictive factors. Pneumon, pages 1-7.
Crossref
Mackenzie Holden, Madeline Fyfe, Camille Poulin, Brianna Bethune, Chloe Church, Paula Hepburn, Vera Afreixo, Dina Brooks & Ana Oliveira. (2021) Handgrip Strength in People With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. Physical Therapy 101:6.
Crossref
Daniel A. Hackett & Angelo Sabag. (2021) Lung function and respiratory muscle strength and their relationship with weightlifting strength and body composition in non-athletic males. Respiratory Physiology & Neurobiology 286, pages 103616.
Crossref
Martijn van Beers, Harry R. Gosker, Daisy J.A. Janssen, Fiona A.H.M. Cleutjens, Frits M.E. Franssen, Martin P.J. van Boxtel, Emiel F. Wouters, Rudolf W.H.M. Ponds & Annemie M.W.J. Schols. (2021) Cognitive performance in relation to metabolic disturbances in patients with COPD. Clinical Nutrition 40:4, pages 2061-2067.
Crossref
Bruna Espíndola de Araújo, Paula Portal Teixeira, Kamila Valduga, Jaqueline da Silva Fink & Flávia Moraes Silva. (2021) Prevalence, associated factors, and prognostic value of sarcopenia in patients with acute exacerbated chronic obstructive pulmonary disease: A cohort study. Clinical Nutrition ESPEN 42, pages 188-194.
Crossref
Xin Wu, Xue Li, Meihong Xu, Zhaofeng Zhang, Lixia He & Yong Li. (2021) Sarcopenia prevalence and associated factors among older Chinese population: Findings from the China Health and Retirement Longitudinal Study. PLOS ONE 16:3, pages e0247617.
Crossref
Kuniaki Hirai, Akihiko Tanaka, Tetsuya Homma, Yuiko Goto, Kaho Akimoto, Tomoki Uno, Uchida Yoshitaka, Yoshito Miyata, Hideki Inoue, Shin Ohta, Shintaro Suzuki & Hironori Sagara. (2021) Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with chronic obstructive pulmonary disease. Clinical Nutrition 40:3, pages 1274-1280.
Crossref
Shivangi Rudra. (2021) Use it or lose it – Sarcopenia and physical activity. Journal of the Indian Academy of Geriatrics 17:3, pages 93.
Crossref
Elizabeth Benz, Katerina Trajanoska, Josje D. Schoufour, Lies Lahousse, Emmely W. de Roos, Natalie Terzikhan, Carolina Medina-Gomez, Katia Verhamme, Ross Williams, Bruno H. Stricker, Oscar H. Franco, M. Arfan Ikram, Fernando Rivadeneira & Guy Brusselle. (2021) Sarcopenia in older people with chronic airway diseases: the Rotterdam study. ERJ Open Research 7:1, pages 00522-2020.
Crossref
Walter Sepúlveda-Loyola, Larissa Araújo de Castro, Andressa Keiko Matsumoto, Carlos Augusto Camillo, Décio Sabbatini Barbosa, Carrie Chueiri Ramos Galvan & Vanessa Suziane Probst. (2021) NOVEL antioxidant and oxidant biomarkers related to sarcopenia in COPD. Heart & Lung 50:1, pages 184-191.
Crossref
Haruyo Matsuo & Kunihiro Sakuma. 2021. Sarcopenia. Sarcopenia 267 293 .
Shiv Bharadwaj, Vivek Dhar Dwivedi, Sang Gu Kang, Nikhil Kirtipal & R. C. Sobti. 2021. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications 233 252 .
Nobuhiro Shimada, Asuka Sakata, Takashi Igarashi, Mamoru Takeuchi & Satoshi Nishimura. (2020) M1 macrophage infiltration exacerbate muscle/bone atrophy after peripheral nerve injury. BMC Musculoskeletal Disorders 21:1.
Crossref
Xueting Li, Fengqiang Xu, Longgang Hu, Hao Fang & Yi An. (2020) Revisiting: “prevalence of and factors associated with sarcopenia among multi-ethnic ambulatory older Asians with type 2 diabetes mellitus in a primary care setting”. BMC Geriatrics 20:1.
Crossref
L. Perrot, A. Greil, Y. Boirie, N. Farigon, A. Mulliez, F. Costes & D. Caillaud. (2020) Prevalence of sarcopenia and malnutrition during acute exacerbation of COPD and after 6 months recovery. European Journal of Clinical Nutrition 74:11, pages 1556-1564.
Crossref
Miroslav Kovarik, Simona Najpaverova, Vladimir Koblizek, Zdenek Zadak & Miloslav Hronek. (2020) Association of resting energy expenditure and nutritional substrate oxidation with COPD stage and prediction indexes. Respiratory Medicine 174, pages 106174.
Crossref
Mariano Mollica, Luigi Aronne, Giorgio Paoli, Martina Flora, Grazia Mazzeo, Stefania Tartaglione, Rita Polito, Carmelindo Tranfa, Maria Ceparano, Klara Komici, Gennaro Mazzarella & Carlo Iadevaia. (2020) Elderly with COPD: comoborbitidies and systemic consequences. Journal of Gerontology and Geriatrics 69:1, pages 32-44.
Crossref
Peter J. Ferrandi, Stephen E. Alway & Junaith S. Mohamed. (2020) The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. Journal of Applied Physiology 129:4, pages 864-867.
Crossref
Shengjie Zhao, Tong Zhang, Bingjie Li, Zhangwei Wu & Jun Zhao. (2020) What Determines Good Rehabilitation Recovery in Stroke Patients with very Severe Disability? A Retrospective Cohort Study. Journal of Stroke and Cerebrovascular Diseases 29:10, pages 105130.
Crossref
Walter Sepúlveda‐Loyola, Christian Osadnik, Steven Phu, Andrea A. Morita, Gustavo Duque & Vanessa S. Probst. (2020) Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysis. Journal of Cachexia, Sarcopenia and Muscle 11:5, pages 1164-1176.
Crossref
Kazuto Matsunaga, Misa Harada, Junki Suizu, Keiji Oishi, Maki Asami-Noyama & Tsunahiko Hirano. (2020) Comorbid Conditions in Chronic Obstructive Pulmonary Disease: Potential Therapeutic Targets for Unmet Needs. Journal of Clinical Medicine 9:10, pages 3078.
Crossref
Tam Ngoc Nguyen, Tu Ngoc Nguyen, Anh Trung Nguyen, Thanh Xuan Nguyen, Huong Thu Thi Nguyen, Thu Thi Hoai Nguyen, Thang Pham & Huyen Thanh Thi Vu. (2020) Prevalence of sarcopenia and its associated factors in patients attending geriatric clinics in Vietnam: a cross-sectional study. BMJ Open 10:9, pages e037630.
Crossref
Sang Hun Kim, Jong Hwa Jeong, Byeong Ju Lee, Myung-Jun Shin & Yong Beom Shin. (2020) Effects of and barriers to hospital-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Physical Therapy Rehabilitation Science 9:2, pages 82-89.
Crossref
Damien Viglino, Francois Maltais & Renaud Tamisier. 2020. Cardiovascular Complications of Respiratory Disorders. Cardiovascular Complications of Respiratory Disorders 12 30 .
Matthias Catteau, Farès Gouzi, Léo Blervaque, Emilie Passerieux, Marine Blaquière, Bronia Ayoub, François Bughin, Jacques Mercier, Maurice Hayot & Pascal Pomiès. (2020) Effects of a human microenvironment on the differentiation of human myoblasts. Biochemical and Biophysical Research Communications 525:4, pages 968-973.
Crossref
Ester Marco, Dolores Sanchez-Rodriguez, Jesús López-Escobar, Delky Meza, Vanesa Dávalos-Yerovi, Xavier Duran, Monique Messaggi-Sartor, Anna Guillén-Solà, Josep M. Muniesa & Esther Duarte. (2020) Is peak expiratory flow an accurate sarcopenia screening tool in older patients referred to respiratory rehabilitation?. European Geriatric Medicine 11:2, pages 297-306.
Crossref
Kuan Ting Tan, Seok‐Ting Jamie Ang & Shih‐Yin Tsai. (2020) Sarcopenia: Tilting the Balance of Protein Homeostasis. PROTEOMICS 20:5-6, pages 1800411.
Crossref
Xiaochen Ji, Wenbin Cui, Boya Zhang & Shiqiang Shan. (2020) Effect of lung protective ventilation on perioperative pulmonary infection in elderly patients with mild to moderate COPD under general anesthesia. Journal of Infection and Public Health 13:2, pages 281-286.
Crossref
Maria Tsekoura, Elias Tsepis, Evdokia Billis & John Gliatis. (2020) Sarcopenia in patients with chronic obstructive pulmonary disease: A study of prevalence and associated factors in Western Greek population. Lung India 37:6, pages 479.
Crossref
Seonggyu Kim, Ye-eun Jeon, Hyeseung Ryu, Mi-Young Lee & Insung Chung. (2020) Related factors for preserving firefighter's pulmonary function. Annals of Occupational and Environmental Medicine 32:1.
Crossref
Atsuyoshi Kawagoshi, Masahiro Iwakura, Yutaka Furukawa, Keiyu Sugawara, Hitomi Takahashi & Takanobu Shioya. (2020) The association between systemic inflammation and the time spent in posture and movement during daytime in patients with chronic obstructive pulmonary disease and lower weight. Journal of Physical Therapy Science 32:12, pages 804-809.
Crossref
Elizabeth Benz, Katerina Trajanoska, Lies Lahousse, Josje D. Schoufour, Natalie Terzikhan, Emmely De Roos, Gerdien B. de Jonge, Ross Williams, Oscar H. Franco, Guy Brusselle & Fernando Rivadeneira. (2019) Sarcopenia in COPD: a systematic review and meta-analysis. European Respiratory Review 28:154, pages 190049.
Crossref
Jiehua Zhi, Qing Shan, Lanyu Liang, Han Liu & Hua Huang. (2019) Low skeletal muscle area as a prognostic marker for chronic obstructive pulmonary disease in elderly patients admitted to ICU. Scientific Reports 9:1.
Crossref
Alison Burton Shepherd & Karen Bowell. (2019) ‘Mind the gap’: the importance of managing malnutrition in chronic obstructive pulmonary disease. British Journal of Nursing 28:22, pages 1442-1449.
Crossref
Samih Raad, Cheryl Smith & Karen Allen. (2019) Nutrition Status and Chronic Obstructive Pulmonary Disease: Can We Move Beyond the Body Mass Index?. Nutrition in Clinical Practice 34:3, pages 330-339.
Crossref
Eun Kyung Choe, Young Lee, Hae Yeon Kang, Seung Ho Choi & Joo Sung Kim. (2019) Association between CT-Measured Abdominal Skeletal Muscle Mass and Pulmonary Function. Journal of Clinical Medicine 8:5, pages 667.
Crossref
Leocadio Rodríguez Mañas & Isabel Rodríguez Sánchez. (2019) Envejecimiento, sarcopenia y fragilidad en el contexto de las enfermedades crónicas respiratorias. Archivos de Bronconeumología 55:3, pages 118-119.
Crossref
Leocadio Rodríguez Mañas & Isabel Rodríguez Sánchez. (2019) Aging, Sarcopenia, and Frailty in Chronic Respiratory Diseases. Archivos de Bronconeumología (English Edition) 55:3, pages 118-119.
Crossref
Demetria Kovelis, Anna Raquel Silveira Gomes, Camila Mazzarin, Andrieli de Miranda & Silvia Valderramas. (2019) Association Between the Results of the Timed Up-and-Go Test Adjusted for Disease Severity and Sarcopenia in Patients with Chronic Obstructive Pulmonary Disease: a Pilot Study. Clinics 74, pages e930.
Crossref
Kamila Mohammad Kamal Mansour, Cássia da Luz Goulart, Luiz Carlos Soares de Carvalho-Junior, Renata Trimer, Audrey Borghi-Silva & Andréa Lúcia Gonçalves da Silva. (2019) Pontos de corte da função pulmonar e capacidade funcional determinantes para sarcopenia e dinapenia em pacientes com DPOC. Jornal Brasileiro de Pneumologia 45:6.
Crossref
Tatiana Rafaela Lemos Lima, Vívian Pinto Almeida, Arthur Sá Ferreira, Fernando Silva Guimarães & Agnaldo José Lopes. (2019) Handgrip Strength and Pulmonary Disease in the Elderly: What is the Link?. Aging and disease 10:5, pages 1109.
Crossref
Sang Hun Kim, Myung Jun Shin, Yong Beom Shin & Ki Uk Kim. (2019) Sarcopenia Associated with Chronic Obstructive Pulmonary Disease. Journal of Bone Metabolism 26:2, pages 65.
Crossref
Yanxia Han, Zhenyun Wu, Yi Chen, Yanan Kan, Min Geng, Nuo Xu, Hongying Qian, Hai Fang Wang & Meie Niu. (2019) Factors associated with appendicular skeletal muscle mass among male Chinese patients with stable chronic obstructive pulmonary disease. Medicine 98:40, pages e17361.
Crossref
Prasun ChatterjeePrasun Chatterjee. 2019. Health and Wellbeing in Late Life. Health and Wellbeing in Late Life 165 195 .
Nadja Scherbakov & Wolfram Doehner. (2018) Do we need a reference standard for the muscle mass measurements?. ESC Heart Failure 5:5, pages 741-744.
Crossref
Chul-Hyun Park, Youbin Yi, Jong Geol Do, Yong-Taek Lee & Kyung Jae Yoon. (2018) Relationship between skeletal muscle mass and lung function in Korean adults without clinically apparent lung disease. Medicine 97:37, pages e12281.
Crossref
Tara Cahill & Mohammed Ahmed. (2018) Muscle Wasting in the Hospitalised COPD Patients—How Can it Be Prevented and Treated?. Current Geriatrics Reports 7:3, pages 147-153.
Crossref
Panita Limpawattana, Pratchaya Inthasuwan, Siraphong Putraveephong, Watchara Boonsawat, Daris Theerakulpisut & Kittisak Sawanyawisuth. (2017) Sarcopenia in chronic obstructive pulmonary disease: A study of prevalence and associated factors in the Southeast Asian population. Chronic Respiratory Disease 15:3, pages 250-257.
Crossref
Kelly C Cushing, Hamed Kordbacheh, Michael S Gee, Avinash Kambadakone & Ashwin N Ananthakrishnan. (2018) Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients. Journal of Crohn's and Colitis.
Crossref
Tatiana Munhoz da Rocha Lemos Costa, Fabio Marcelo Costa, Thaísa Hoffman Jonasson, Carolina Aguiar Moreira, César Luiz Boguszewski & Victória Zeghbi Cochenski Borba. (2018) Body composition and sarcopenia in patients with chronic obstructive pulmonary disease. Endocrine 60:1, pages 95-102.
Crossref
Francesca de Blasio, Ada Di Gregorio, Francesco de Blasio, Andrea Bianco, Barbara Bellofiore & Luca Scalfi. (2018) Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables. Respiratory Medicine 134, pages 1-5.
Crossref
Jonathan Dando. 2018. Myogenesis in Development and Disease. Myogenesis in Development and Disease 1 22 .